|

Local Standard of Care Clinical Trials

2 actively recruiting trials

Also known as: Bevacizumab, Everolimus, Hydroxycarbamide, No active treatment (observation with regular follow-up and best supportive care), Octreotide (Sandostatin LAR) +1 more

Pipeline

Phase 2: 2

Top Sponsors

  • Istituto Oncologico Veneto IRCCS1
  • European Organisation for Research and Treatment of Cancer - EORTC1

Indications

  • Cancer2
  • Recurrent Meningioma1
  • Meningioma, Malignant1

Other2 trials

177Lu-DOTATATE for Recurrent Meningioma
Phase 2
Regorafenib for Recurrent Meningioma (MIRAGE Trial)
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.